Pharma Ag Novartis, 10% Owner at IDENIX PHARMACEUTICALS INC (IDIX), bought 17,083 shares at $2.41 ($47K) on 2010-11-26, disclosed to the SEC on 2010-11-26.
Open-market purchase of $47k IDIX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.41 | 14,234 | $34K | 73.5% |
| 2 | $2.64 | 822 | $2K | 4.6% |
| 3 | $2.96 | 44 | $130 | 0.3% |
| 4 | $3.79 | 165 | $625 | 1.3% |
| 5 | $5.11 | 1,332 | $7K | 14.6% |
| 6 | $5.46 | 486 |
| $3K |
| 5.7% |
| Total | $2.73 avg | 17,083 | $47K | 100% |
| Filing → |
| IDIX | BUY | 2011-12-09 | $115K | — | Filing → |
| IDIX | BUY | 2011-11-22 | $206K | — | Filing → |
| IDIX | BUY | 2010-09-16 | $91K | — | Filing → |